Epirium Bio

company

About

Epirium Bio is a biopharmaceutical company developing a small molecule platform targeting improvements in muscle strength.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$85M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

Epirium Bio is a biopharmaceutical company based in San Diego, is developing a small molecule platform targeting improvements in muscle strength, tissue regeneration, and mitochondrial function.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$85M
Epirium Bio has raised a total of $85M in funding over 2 rounds. Their latest funding was raised on Dec 18, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 18, 2019 Series A $85M 1 ARCH Venture Partners Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Epirium Bio is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Yes Series A